This compound is primarily utilized in pharmaceutical research and development, particularly in the synthesis of chiral compounds and active pharmaceutical ingredients (APIs). It serves as a key intermediate in the production of drugs targeting neurological disorders, including those related to GABAergic systems, due to its structural similarity to GABA (gamma-aminobutyric acid). Additionally, it is employed in the study of enzyme inhibitors and receptor modulators, aiding in the exploration of therapeutic agents for conditions like epilepsy, anxiety, and chronic pain. Its chiral nature also makes it valuable in asymmetric synthesis, contributing to the creation of enantiomerically pure substances with enhanced efficacy and reduced side effects.